SCHEMBL30079591

SCHEMBL30079591

Cn1cc([N+](=O)[O-])c(CNC2CCN(C(=O)OC(C)(C)C)CC2)n1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
EPHX1 P07099 1/20 0.41
MAPT P10636 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NPC1 O15118 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 1/20 0.41
GPR119 Q8TDV5 7/20 0.40
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
PTPN6 P29350 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
USP30 Q70CQ3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30079238 0.85 ALDH1A1 (0.45) ALDH1A1EPHX1MAPTL3MBTL1NPC1
SCHEMBL30079142 0.80 ALDH1A1 (0.44) ALDH1A1EPHX1MAPTL3MBTL1NPC1
SCHEMBL2102000 0.79 ALDH1A1 (0.57) ALDH1A1EPHX1MAPTL3MBTL1NPC1
SCHEMBL17140284 0.78 ALDH1A1 (0.42) ALDH1A1EPHX1MAPTL3MBTL1NPC1
SCHEMBL27182163 0.78 ALDH1A1 (0.43) ALDH1A1EPHX1MAPTL3MBTL1NPC1
SCHEMBL16463677 0.77 EPHX2 (0.43) ALDH1A1EPHX1MAPTL3MBTL1NPC1
SCHEMBL17140268 0.77 ALDH1A1 (0.43) ALDH1A1EPHX1MAPTL3MBTL1NPC1
SCHEMBL30079605 0.77 EPHX1 (0.46) ALDH1A1EPHX1MAPTL3MBTL1NPC1
SCHEMBL5012643 0.77 ALDH1A1 (0.58) ALDH1A1EPHX1MAPTL3MBTL1NPC1
SCHEMBL16463566 0.76 GPR119 (0.44) ALDH1A1MAPTL3MBTL1NPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737684-B1 2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES IDORSIA PHARMACEUTICALS LTD (CH) 2022-11-16 EP disclosed